1. Scrip
  2. >>Business
  3. >>Strategy

Sanofi, Google’s Verily Enter Diabetes JV To Produce Joined Up Solutions

 
• By Sten Stovall

Sanofi’s diabetes head says French drug maker’s JV pact with Google’s Verily will combine novel therapies for the condition with cutting edge technologies to produce better focused, outcome-based combinations.

Stefan Oelrich
Sanofi Global Diabetes Franchise Head Stefan Oelrich • Source: Sanofi

A joint venture being established by Sanofi and Google parent Alphabet aims to combine medicines, devices and software into a joined up portfolio of product offerings for diabetes patients around the world, according to the head of the French drug maker’s global diabetes franchise.

The US-based JV, named Onduo, was announced Sept 12 as a unique alliance focus on helping type 2...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business

Skyhawk Looks To Soar With Huntington’s Hope

 
• By Kevin Grogan

Oral RNA splicing modulator has gone into a Phase II/III trial

BIO Notebook: MFN Pricing, Next-Gen Obesity R&D, FDA’s Rare Disease Hub & Reaction To Review Program

 
• By Sarah Karlin-Smith, Mandy Jackson, and Alaric DeArment

Highlights from Day 3 of the BIO International Convention include the realities of MFN pricing, AstraZeneca's R&D plans for obesity, the need for resources for FDA's rare disease hub and reactions to the Commissioner's National Priority Review Voucher program.

EY Recommends Focusing On Fundamentals, Waiting For Prime Deal Conditions

 
• By Joseph Haas

Government policy ramifications and tight financial markets mean it’s time to prepare strategically for a better business development environment, EY suggests.